TradingView
RocketTickers
Jan 4, 2022 8:49 PM
AbbVie Announces U.S. FDA Granted Breakthrough Therapy Designati
Long
NYSE:ABBV
1D
AbbVie Inc.
NYSE
Description
⋅
Jan 4, 2022 8:49 PM
ABBV: AbbVie Inc.
2022-01-04 08:15:00
AbbVie Announces U.S. FDA Granted Breakthrough Therapy Designation (BTD) to Telisotuzumab Vedotin (Teliso-V) for Previously Treated Non-Small Cell Lung Cancer
Beyond Technical Analysis
More